Medicines, 2018
Shortlist up to four to read them side by side.
1,426 medicine recalls FDA’s Enforcement Report published in 2018, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,426of 1,426 medicine recallsshown with your filters
The list
- Medicine recall Labetalol HCl in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Methadone HCl Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Midazolam HCl Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Fentanyl Citrate Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ephedrine Sulfate Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ketamine HCl Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ropivacaine HCl Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Glycopyrrolate in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Lidocaine HCl Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Atropine Sulfate Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall HYDROmorphone HCl Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ropivacaine HCl Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Nicardipine HCl in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Labetalol HCl Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Neostigmine Methylsulfate Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Vecuronium Bromide in Sterile Water for Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Dexamethasone Sodium Phosphate added to 0.9% Sodium Chloride in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Esmolol HCl in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Meperidine HCl Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Methadone HCl Injection in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Rocuronium Bromide in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Dexamethasone Sodium Phosphate added to 5% Dextrose in all strengths, all doses, and all packaging. Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Nicardipine HCl Lack of sterility assurance. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle Presence of Foreign Tablets/Capsules Class IIIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Amitriptyline HCl USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Anastrozole USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Baclofen USP (Micronized) for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Calcipotriene BP (Monohydrate) for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Celecoxib USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Clindamycin Phosphate USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Clonidine HCl USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Cyclobenzaprine HCl USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Cyclosporine USP, for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Desoximetasone USP (Micronized) for prescription compounding, 5g CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Diclofenac Sodium USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Diphenhydramine HCl USP f (or prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Doxycycline Hyclate USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Duloxetine HCl USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Estradiol USP (Micronized) (Yam) for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Estradiol Hemihydrate USP (Micronized) (Soy) for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Estriol USP (Micronized) (Yam) for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Estrone USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Fluconazole USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Flurbiprofen USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Gabapentin USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Hydroxyprogesterone Caproate USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Imiquimod USP for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Itraconazole USP (Micronized) for prescription compounding CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm’s container/closure system. Class IIFDA’s classFeb 28, 2018in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedFeb 28, 2018ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.